Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2008
10/29/2008EP1984354A1 Pesticides containing a bicyclic bisamide structure
10/29/2008EP1984353A1 Aurora kinase modulators and method of use
10/29/2008EP1984345A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
10/29/2008EP1984338A2 Pyridylphenyl compounds for inflammation and immune-related uses
10/29/2008EP1984332A2 Methods for treating hepatitis c
10/29/2008EP1984331A1 Pyrrolidine derivatives as erk inhibitors
10/29/2008EP1984330A1 Chemical compounds
10/29/2008EP1983994A2 Oxazole ketones as modulators of fatty acid amide hydrolase
10/29/2008EP1983993A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/29/2008EP1983986A2 Piperidine derivatives as cxcr3 receptor antagonists
10/29/2008EP1891038B1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
10/29/2008EP1727809B8 Substituted morpholine and thiomorpholine derivatives
10/29/2008EP1687284B1 p-38 KINASE INHIBITORS
10/29/2008EP1664016B1 Therapeutic agents useful for treating pain
10/29/2008EP1641758B1 Diphenylpyridine derivatives, preparation and therapeutic application thereof
10/29/2008EP1531811B1 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
10/29/2008CN101296925A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101296910A Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
10/29/2008CN101296907A Diaminopyrimidines as P2X3 and P2X2/3 modulators
10/29/2008CN101296903A Novel indole-containing beta agonists, method for producing them and their use as drugs
10/29/2008CN101296731A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101293876A Benzoxazole ketones derivative and preparation method thereof
10/29/2008CN100429206C Benzoxazine derivatives as 5-HT6 modulators and uses thereof
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/28/2008US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
10/28/2008US7442795 Triazole compounds useful in therapy
10/28/2008US7442716 e.g. 2-[9-chloro-6-(3-hydroxy-3-methylbutyl-1-yn-1-yl)-1H-phenanthro[9,10-d]imidazol-2-yl]-3-fluorobenzonitrile; microsomal prostaglandin E synthase inhibitor; analgesic, antiinflammatory agent; osteoarthritis, rheumatoid arthritis and acute or chronic pain; side effect reducer
10/28/2008US7442710 Substituted phenyl methanones
10/28/2008US7442705 HIV replication inhibiting pyrimidines and triazines
10/28/2008US7442704 Amide derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442698 Substituted heterocyclic compounds and methods of use
10/28/2008US7442691 Macrocycles useful in the treatment of alzheimer's disease
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2331141C Water soluble azoles as broad-spectrum antifungals
10/23/2008WO2008128166A1 Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
10/23/2008WO2008127464A1 Heterocyclic compounds and their methods of use
10/23/2008WO2008127361A2 Synthesis of enone intermediate
10/23/2008WO2008127300A2 Oxazolidinone derivatives and methods of use
10/23/2008WO2008127275A2 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
10/23/2008WO2008127025A1 A novel heterocycle or alkoxyaminomethyl oxazolidinone derivative and manufacturing process thereof
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126665A2 Isoxazoline compounds and their use in pest control
10/23/2008WO2008126024A2 Oxazolidinone antibiotic derivatives
10/23/2008WO2008125811A1 N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
10/23/2008WO2008125570A1 New bradykinin b1 antagonists
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008WO2008053341A3 Bridged bicyclic indazoles as cannabinoid receptor ligands
10/23/2008US20080262225 Manganese, titanium, iron, cobalt, nickel, or copper with ligand
10/23/2008US20080262056 (S) N-[3-(1-methyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide; staphylococci, streptococci, Enterococci, Haemophilus, Moraxella, bacteroides, clostridia, Mycobacteria, or Chlamydia
10/23/2008US20080262052 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
10/23/2008US20080262032 Isoxazoline Derivative and Novel Process for Its Preparation
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261979 Phenyl-1,2,4-Oxadiazolone Derivatives, Processes For Their Preparation and Methods For Their Use as Pharmaceuticals
10/23/2008US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea
10/23/2008US20080261977 Pyrimidine Derivatives as Cannabinoid Receptor Modulators
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261968 Heterobicyclic metalloprotease inhibitors
10/23/2008US20080261967 Modulators of Central Nervous System Neurotransmitters
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261965 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
10/23/2008US20080261961 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
10/23/2008US20080261953 Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080261950 Drug hybrid of rivastigmine or physostigmine with tranylcypromine, amoxapine, desipramine, nortriptyline, protriptyline, fluoxetine, fluvoxamine, paroxetine, duloxetine, betahistine, amlodipine, proylhexedrine, rimantadine, desloratadine; Alzheimer's disease; Parkinson's disease, impairment in memory
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261944 Indole Derivatives as Antiviral Agents
10/23/2008US20080261940 N-(1-Arylpyrazol-4L) Sulfonamides and their Use as Parasiticides
10/23/2008US20080261920 Treat diseases related to biological function of trace amine associated receptors; depression, anxiety, bipolar, attention deficit hyperactivity, psychosis; includes all racemic mixtures, isomers; (S)-4-(2-chloro-phenyl)-4,5-dihydro-oxazol-2-ylamine
10/23/2008US20080261314 Fluorescent probe for zinc
10/23/2008CA2681787A1 Heterocyclic compounds and their methods of use
10/23/2008CA2679069A1 Oxazolidinone antibiotic derivatives
10/22/2008EP1982978A1 Pyridone derivative and herbicide
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008EP1981882A1 Amide substituted quinolines
10/22/2008EP1981871A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981870A2 Compounds and compositions as protein kinase inhibitors
10/22/2008EP1981860A2 Conversion of aromatic diazonium salt to aryl hydrazine
10/22/2008EP1981858A2 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents
10/22/2008EP1981856A2 Pyrimidine derivatives
10/22/2008EP1981854A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/22/2008EP1981847A1 Secondary amines as renin inhibitors
10/22/2008EP1981508A2 Potassium channel inhibitors
10/22/2008EP1910351B1 Colourless water-soluble organic luminophores and intermediates thereof
10/22/2008EP1756089B1 Mercaptoimidazoles as ccr2 receptor antagonists
10/22/2008EP1648879B1 Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291930A Tricyclo substituted amides
10/22/2008CN101291929A Tricyclo substituted amides
10/22/2008CN101291924A Isoindole-imide compounds and compositions comprising and methods of using the same
10/22/2008CN101291922A 烷基喹啉和烷基喹唑啉类激酶调节剂 Alkyl quinoline and alkyl quinazoline kinase modulators
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN100427499C Soluble salt of azithromycin and its preparation process
1 ... 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 ... 647